Violet Shen - Concepedia

Concepedia

Author

Violet Shen

Children's Hospital of Orange County ORCID

Also Known As

Shen, V. J., V Shen, V. Shen, Violet Shen

62

Publications

1.7K

Citations

20

H-Index

81

Concepts

All Affiliations

Children's Hospital of Orange County University of California, Irvine Children's Hospital of Los Angeles St. Jude Children's Research Hospital The University of Texas MD Anderson Cancer Center

VS

About

Violet Shen is an author at Children's Hospital of Orange County specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	558
2	Health Sciences	4	4	88
3	Education	1	1	22
4	Social Sciences	1	1	22
5	Anatomy	1	1	25

Violet Shen

×

30

Publications

1.7K

Citations

20

H-Index

	Year	Citations
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia Sima Jeha, Paul S. Gaynon, Bassem I. Razzouk, Journal of Clinical Oncology	2006	304
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial Sima Jeha, H. Kantarjian, David Irwin, Leukemia Urological ResearchUrologyInherited Metabolic DiseaseClinical TrialsGeriatric Urology	2004	178
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia Nobuko Hijiya, Blythe Thomson, Michael S. Isakoff, Blood	2011	122
Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production Mei Chang, Y Suen, James B. Bussel, Blood	1996	109
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience Wafik Zaky, Girish Dhall, Lingyun Ji, Pediatric Blood & Cancer	2013	105
Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children’s Cancer Group Mark T. Jennings, Richard Sposto, James M. Boyett, Journal of Clinical Oncology	2002	103
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation–Positive Solid Tumors Mark W. Kieran, Birgit Geoerger, Ira J. Dunkel, Clinical Cancer Research	2019	91
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia Nobuko Hijiya, Paul S. Gaynon, Elly Barry, Leukemia Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaHematology	2009	85
Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments Pete Anderson, Paul A. Meyers, Eugenie S. Kleinerman, Pediatric Blood & Cancer	2013	68
Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report Mitchell S. Cairo, Violet Shen, Mark Krailo, The American journal of pediatric hematology/oncology	2001	56

Page 1